Quantum BioPharma Ltd. (QNTM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 125.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -125.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.74M | -7.95M | 4.75M | 4.85M | 3.4M | 6.24M | 4.18M | 3.46M | 2.26M | 1.8M | 3.31M | 8.83M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.13M | 2.16M | 4.02M | 4.22M | 1.61M | 1.69M | 3.21M | 2.44M | 1.97M | 1.81M | 2.69M | 2.74M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 617.42K | 70.4K | 495.22K | 549.2K | 1.65M | 4.28M | 744.8K | 897.99K | 160.26K | -29.96K | -32.98K | 1.61M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 234.74K | 81.03K | 141.49K | 267.22K | 228.77K | 122.53K | 124.28K | 21.98K | 658.92K | 1000K |
| Operating Income | -2.87M | 7.95M | -4.75M | -4.85M | -3.4M | -6.24M | -4.18M | -3.46M | -2.26M | -1.8M | -3.31M | -8.83M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 15.55% | 227.4% | -13.55% | -40.41% | -50.5% | -246.52% | -26.24% | 60.86% | 77.07% | 72.96% | 54.35% | -12.27% |
| EBITDA | -2.74M | 8.08M | -4.6M | -4.71M | -3.27M | -6.13M | -4.06M | -3.32M | -2.14M | -1.68M | -3.17M | -7.72M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 16.04% | 231.86% | -13.35% | -41.94% | -52.9% | -265.02% | -28.28% | 57.02% | 75.48% | 69.5% | 48.18% | -14.72% |
| D&A (Non-Cash Add-back) | 125.67K | 129.37K | 145.34K | 141.38K | 129.69K | 112.8K | 120.81K | 136.81K | 120.14K | 122.22K | 146.81K | 1.11M |
| EBIT | -2.87M | -3.78M | -4.64M | -9.53M | -8.39M | -5.44M | -4M | -3.34M | -2.08M | -1.65M | -2.8M | -5.49M |
| Net Interest Income | -44.56K | 0 | -4.66K | -144.84K | -283.4K | 115.64K | 153.5K | 96.07K | 160.11K | 153.78K | 174.07K | 186.16K |
| Interest Income | 0 | 0 | 100.42K | 90.73K | 67.22K | 132.07K | 163.87K | 104.42K | 172.52K | 153.79K | 174.07K | 186.16K |
| Interest Expense | 44.56K | 0 | 105.08K | 235.57K | 350.62K | 16.43K | 10.37K | 8.36K | 12.41K | 12 | 0 | 0 |
| Other Income/Expense | -10.69M | -11.65M | 0 | -4.91M | -5.34M | 784.95K | 165.74K | 104.11K | 165.93K | 149.56K | 2.18M | 3.34M |
| Pretax Income | -13.56M | -3.7M | -4.75M | -9.77M | -8.74M | -5.46M | -4.02M | -3.35M | -2.09M | -1.65M | -1.13M | -5.49M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -13.37M | -3.03M | -5.32M | -9.25M | -8.58M | -5.36M | -3.83M | -3.11M | -1.9M | -1.32M | -1.06M | -5.49M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -55.92% | 43.54% | -38.98% | -197.34% | -350.61% | -305.11% | -261.11% | 43.32% | 80.89% | 78.48% | 85.13% | -24.1% |
| Net Income (Continuing) | -13.56M | -3.7M | -4.75M | -9.77M | -8.74M | -5.46M | -4.02M | -3.35M | -2.09M | -1.65M | -1.13M | -5.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -2.02M | -1.82M | -1.15M | -1.72M | -1.2M | -1.04M | -944.29K | -756.13K | -515.55K | -327.5K | -89.53K | 0 |
| EPS (Diluted) | -2.98 | -0.79 | -1.40 | -3.23 | -7.52 | -5.22 | -4.17 | -4.85 | -3.12 | -2.18 | -1.76 | -9.10 |
| EPS Growth % | 60.37% | 84.87% | 66.43% | 33.4% | -141.03% | -139.45% | -136.93% | 46.7% | 81.22% | 78.81% | 85.49% | -21.82% |
| EPS (Basic) | -2.98 | -0.79 | -1.40 | -3.23 | -7.52 | -5.22 | -4.17 | -4.85 | -3.12 | -2.18 | -1.76 | -9.10 |
| Diluted Shares Outstanding | 4.49M | 3.89M | 3.8M | 3.02M | 1.14M | 1.03M | 917.85K | 641.16K | 610.03K | 606.01K | 602.96K | 603.6K |
| Basic Shares Outstanding | 4.49M | 3.89M | 3.8M | 3.02M | 1.14M | 1.03M | 917.85K | 641.16K | 610.03K | 606.01K | 602.96K | 603.6K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |